| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/06/2005 | CN1209355C Derivate of sweetsop lactone as well as preparation method and usage |
| 07/06/2005 | CN1209354C Salt of phenylacetyl-(N-methyl)leucine-aspartic acid- phenylalanine-(N-methyl)piperazine |
| 07/06/2005 | CN1209353C Estrogen agonist/antagonist metabolites |
| 07/06/2005 | CN1209352C Hydrazine derivatives |
| 07/06/2005 | CN1209351C N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as CCR3 receptor antagonists |
| 07/06/2005 | CN1209164C Compositions comprising DNA damaging agents and P53 |
| 07/06/2005 | CN1209161C Medicine for external application for treating cervical erosion |
| 07/06/2005 | CN1209158C Lung clearing oral liquid preparation for treating viral pneumonia in Children and preparing method thereof |
| 07/06/2005 | CN1209147C Medicinal power for treating trauma |
| 07/06/2005 | CN1209143C Pharmaceutical composition for treating hepatitis |
| 07/06/2005 | CN1209138C Medicine composition for tumour and its preparation method |
| 07/06/2005 | CN1209134C Chinese traditional medicine for treating cerebral thrombus and method for preparing the same |
| 07/06/2005 | CN1209133C Medicine for preventing and treating rachitis and osteoporosis and method for preparing the same |
| 07/06/2005 | CN1209120C External applied paste as antidiarrheal |
| 07/06/2005 | CN1209119C Powder for treating eye disease and preparing method thereof |
| 07/06/2005 | CN1209117C Small pellet of extraction of kudzu vine, and its preparation method |
| 07/06/2005 | CN1209116C Application of akebia saponin D in preparation of medicine for preventing and treating osteopathia |
| 07/06/2005 | CN1209115C Active extracted composition of teasel root and notoginseng and its use in medicine |
| 07/06/2005 | CN1209114C Use of N-acetyl-D-aminoglucose in preparation of skin membrane mucosa microecologica balance regulator medicine |
| 07/06/2005 | CN1209113C Tincture for treating psoriasis |
| 07/06/2005 | CN1209112C Smilagenin and anzurogenin-D for treating Alzheimer's disease |
| 07/06/2005 | CN1209111C Use of antiprogestins for the induction of apoptosis in a programming cell |
| 07/06/2005 | CN1209110C Novel iron chelator as inhibitor of iron-mediated oxidation |
| 07/06/2005 | CN1209109C Slow-releasing acipimox tablet |
| 07/06/2005 | CN1209108C Trans-dermal composition of anti-vomiting agent and preparation containing the same |
| 07/06/2005 | CN1209107C Carbazolyl alkaloid anticarcinogen and its prepn |
| 07/06/2005 | CN1209106C Use of ellagic acid as anti-pollution cosmetic agent |
| 07/06/2005 | CN1209105C Coronary artery skeleton medicinal coating for preventing restenosis of blood vessel |
| 07/06/2005 | CN1209104C Neohouttuynin sodium freeze-dried powder-injection, and its prepn. method |
| 07/06/2005 | CN1209103C Fenofibrate soft capsule and its preparation method |
| 07/06/2005 | CN1209102C Arginine acetate oral preparation and clinical application thereof |
| 07/06/2005 | CN1209101C Metformin hydrochloride sustained-release tablet and method for preparing the same |
| 07/06/2005 | CN1209099C Agglomerates by crystallisation |
| 07/06/2005 | CN1209098C Methods and devices for providing prolonged drug therapy |
| 07/05/2005 | US6914168 Does not entail dipping a body portion into hot paraffin by applying strip containing the flowable paraffin composition to a portion of skin of the patient |
| 07/05/2005 | US6914160 Oxytocin inhibitors |
| 07/05/2005 | US6914158 Amidino compounds useful as nitric oxide synthase inhibitors |
| 07/05/2005 | US6914148 Monomer for use in huaman therapeutics and diagnostics |
| 07/05/2005 | US6914141 Useful as inhibitor of platelet agglomeration |
| 07/05/2005 | US6914122 Macrocyclic NS-3 serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties |
| 07/05/2005 | US6914080 Amine compounds and inhibiting neurotransmitter reuptake |
| 07/05/2005 | US6914078 Triarylmethane derivatives and their use as photochemotherapeutic agents |
| 07/05/2005 | US6914076 Administering carnitine after each dialysis session; repeated twice a week every 44 hours, then after 68 hours. |
| 07/05/2005 | US6914075 Cystine derivative and agent for suppressing activation of inflammatory factors |
| 07/05/2005 | US6914074 For therapy and prophylaxis of prostatitis or interstitial cystitis, inflammatory bowel disease, Crohn's disease, ulcerative proctitis, or colitis, prostatic hypertrophy, uterine leiomyomas, breast cancer, endometrial cancer |
| 07/05/2005 | US6914073 Multivitamin/multimineral optimized for cardiovascular health containing increased levels of Vitamin E; does not leach vitamin E |
| 07/05/2005 | US6914072 E.g., ajulemic acid; used for decreasing cell proliferation |
| 07/05/2005 | US6914070 Ophthalmic compositions for treating ocular hypertension |
| 07/05/2005 | US6914069 Pharmaceutically active compounds and methods of use |
| 07/05/2005 | US6914067 Compositions and methods for the treatment of colorectal cancer |
| 07/05/2005 | US6914066 1,2-annelated quinoline derivatives |
| 07/05/2005 | US6914064 1,4-Disubstituted piperazine derivatives useful as uro-selective α1-adrenoceptor blockers |
| 07/05/2005 | US6914063 Imidazo-pyrazine derivatives as ligands for GABA receptors |
| 07/05/2005 | US6914060 Treatment of anxiety, convulsions and cognitive disorders |
| 07/05/2005 | US6914059 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments |
| 07/05/2005 | US6914058 1-(p-(thiomorpholino)phenyl)-1,2,3-triazole derivatives |
| 07/05/2005 | US6914057 Inhibitor of cataract formation |
| 07/05/2005 | US6914056 Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation |
| 07/05/2005 | US6914055 Cancer therapeutic formulation having reduced toxicity comprising a galactomannan, and a chemotherapeutic agent |
| 07/05/2005 | US6914054 Treatment with a 1' 2' and/or 3' nucleoside or a pharmaceutically acceptable salt or prodrug; nontoxic |
| 07/05/2005 | US6914053 5-(hydroxymethyl)- or aminocarbonyl-2-(6-(alkoxyamino)-2-(optionally substituted ethynyl)purin-9-yl)tetrahydrofuran-3,4-diol derivatives; treatment of ischemia, asthma, leukopenia and neutropenia, cancer and inflammation. |
| 07/05/2005 | US6914052 Dideoxynucleoside analog compounds containing a dideoxy ribofuranosyl moiety that exhibit selective anti-viral activity coupled with substantially low toxicity toward host cells; treatment of HIV |
| 07/05/2005 | US6914051 Penetrating antibiotic gel for soft tissue diseases |
| 07/05/2005 | US6914046 Administering human growth hormone having a specific amino acid sequence to cancer patients who are resistant to, or at risk of developing a resistance to a NF-kappa B-activating cytotoxic molecule |
| 07/05/2005 | US6913926 Use of a pituitary tumor transforming gene peptide which has the ability to regulate endogenous PTTG1 expression and/or function in a dominant negative manner |
| 07/05/2005 | US6913892 Method of obtaining compositions comprising Y4 specific compounds |
| 07/05/2005 | US6913779 Process for the preparation of accelerated release formulations using compressed fluids |
| 07/05/2005 | US6913772 Composition useful as hepatoprotectants comprising extract of plant Cryptolepis buchanani and a method thereof |
| 07/05/2005 | US6913769 Treatment of hangover after alcohol comsumption |
| 07/05/2005 | US6913768 Attention deficit disorders |
| 07/05/2005 | US6913764 Antibiotic(s) preparation with retarding active ingredient release |
| 07/05/2005 | US6913761 Sustained drug delivery |
| 07/05/2005 | US6913760 Polymer and a pain-relieving combination of an anesthetic agent and an analgesic agent. |
| 07/05/2005 | US6913759 Gel composition and method for treatment of vaginal infections |
| 07/05/2005 | US6913744 Administering collagenase and other enzymes; side effect reduction |
| 07/05/2005 | US6913099 Mounting configuration and method for a motorcycle seat |
| 07/05/2005 | CA2360677C Anticonvulsant derivatives useful in treating bulimia nervosa |
| 07/05/2005 | CA2327439C Combination therapy for the treatment of tumors |
| 07/05/2005 | CA2309485C New 4-arylpiperidine derivatives for the treatment of pruritus |
| 07/05/2005 | CA2274910C Flat medicament preparation for the application and release of buprenorphine or a pharmacologically comparable substance in the buccal cavity, and method of producing the same |
| 07/05/2005 | CA2265635C Skin care compositions containing combinations of compounds for mimicking the effect on skin of retinoic acid |
| 07/05/2005 | CA2264250C Tablet with controlled release of alfuzosin hydrochloride |
| 07/05/2005 | CA2253545C Phosphatidic acid-comprising compositions |
| 07/05/2005 | CA2230082C Amide compounds and use thereof |
| 07/05/2005 | CA2220509C Fused polycyclic heterocycle derivatives |
| 07/05/2005 | CA2215793C Use of neuronal apoptosis inhibitor protein (naip) |
| 07/05/2005 | CA2199679C Dimethyl-(3-aryl-but-3-enyl)-amine compounds as pharmaceutical active ingredients |
| 07/05/2005 | CA2183972C Oxazolidinone derivatives and pharmaceutical compositions containing them |
| 07/05/2005 | CA2179530C Cyclic polyamines |
| 07/05/2005 | CA2165446C Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade |
| 07/05/2005 | CA2160928C Compounds as pde iv and tnf inhibitors |
| 07/05/2005 | CA2160128C Urea and amide derivatives and their use in the control of cell membrane potassium channels |
| 07/05/2005 | CA2151377C Aminomethylindans, -benzofurans and -benzothiophenes |
| 07/05/2005 | CA2119572C Oxygen substituted derivatives of nucleophile-nitric oxide adducts as nitric oxide donor prodrugs |
| 07/05/2005 | CA2118928C Saponin-antigen conjugates and the use thereof |
| 07/05/2005 | CA2101101C Skin care compositions comprising a retinoid and an imidazole |
| 07/05/2005 | CA2093946C Methanediphosphonic acid formulations with ion exchangers |
| 07/05/2005 | CA2089748C Pharmaceutical compositions containing 5-difluoromethoxy-2-[(3,4-dimethoxy-2-pyridyl) methylsulfinyl]benzimidazole and an anti-helicobacter agent for the treatment of gastrointestinal disorders |
| 07/05/2005 | CA2072541C Heterocyclic compounds, their production and use |
| 07/05/2005 | CA2064382C Pharmaceutical compounds |